July 3, 2025
Michael Yeadon earned a PhD in respiratory pharmacology and held senior roles at Pfizer until 2011, focusing on allergy and respiratory drug research. After leaving Pfizer, he co-founded Ziarco, a biotech firm later acquired by Novartis.